KR100470978B1 - Yeast mutant strains deficient in the multiple yapsin genes and method for the production of recombinant proteins using the same - Google Patents

Abstract

The present invention relates to an auxin multiple-defective yeast mutant strain and a method for producing a recombinant protein using the same. More specifically, at least one of the auxin 6 and auxin 7 genes encoding a protease of the yeast Saccharomyces cerevisiae apsin family The present invention relates to a deleted mutant strain and a method for mass production of a recombinant protein using the mutant strain. Apsin multiple-defective yeast strain of the present invention can be useful industrially by reducing the protease activity of cleaving the extracellular secreted recombinant protein can be isolated and purified intact form of the protein of interest.

Description

{Yeast mutant strains deficient in the multiple yapsin genes and method for the production of recombinant proteins using the same}

The present invention relates to a mutant strain lacking the Apsin gene, and more particularly, to a mass production method of an Apsin multiple-defective yeast mutant strain in which at least one of the genes encoding the Apsin family of proteases is deleted, and a recombinant protein using the same.

Traditional yeast In the case of Saccharomyces cerevisiae Not only is the genetic manipulation easy Since the strain itself and its characteristics in fermentation culture are well known, it is widely used as an industrial strain for mass production of useful recombinant proteins. Above all, Saccharomyces cerevisiae is a single-celled eukaryotic microorganism with a secretory pathway very similar to that of higher eukaryotic cells, making it a very useful host cell for the production of secretory proteins derived from higher animals like human proteins. . In addition, the production of recombinant proteins using a yeast secretion expression system has the advantage that the recombinant protein separation process is very simple because there are few proteins secreted out of the cells by the yeast itself (Ramanos et al., Yeast , 1992, 8, 423).

Although Saccharomyces cerevisiae has long been considered to have little protease secreted out of cells, recent studies on expression of recombinant protein secretion using Saccharomyces cerevisiae have been performed out of the cells by proteases produced in the yeast itself. It has been shown that it breaks down foreign proteins and shows that this is a major factor that hinders the final productivity of foreign proteins (Ramanos et al., Yeast , 1992, 8, 423). In particular, this phenomenon is particularly prominent at the end of high concentration culture of yeast, and is caused by the release of protease naturally released from the host cell or present in the cell through cell lysis (Alvarez et al. al., J. Biotechnol., 1994, 38, 81; Chen et al ., Curr. Genet., 1995, 27, 201; Hinnen et al., In Gene expression in recombinant microorganisms (ed. Smith A.), 1995 , 121).

Recently, a single or a pair of basic amino acids are recognized and cleaved, and yapsin of the yeast aspartic protease family in the cell membrane has been found in Saccharomyces cerevisiae ( Egel-Mitani et al., Yeast, 1990, 6, 127). Recently published yaccin1 (yapsin1) (formerly known as yeast aspartic protease 3 ( YAP3 )) among yeast aspartic proteases, according to the recently published Saccharomyces cerevisiae genome information, and the subsequently discovered apsin2 (formerly known as yeast aspartic protease 3 ( YAP3 )) are known as MKC7) (Komano et al., Proc. Natl. At least such Acad. Sci. USA., 1995 , aepsin a proteolytic enzyme speculated that in addition to having a similar function 7, 10,752) 3, aepsin 6 and aepsin 7 Genes encoding more than five aepsin phyllolytic enzymes have been reported (Olsen et al., Biochem. J., 1999, 339). A saccharide as MY access celebrity bicyclic Ke aepsin homology YPS2 is 53% of the genes YPS1 of, YPS3 was 47%, YPS5 is 38%, YPS6 has shown a homology of 36%, YPS7 has homology of 27% Seems. YPS5 is considered a pseudo gene that encodes incomplete apsin . These absines cut basic amino acid residues that are present in single or pair as opposed to other aspartic proteases that cut hydrophobic residues and share a commonality that is located on the cell surface via the GPI anchor (glycosylphosphatidylinositol anchor). Although their physiological function has not yet been clearly identified, given their location within the cells, these aptins are thought to function to process precursors of cell walls or precursors of enzymes involved in cell wall synthesis (Josee et al. , Biochem J., 1995, 270, 20847). In addition, Apsin 1 and Apsin 2 were assumed to play an important role in stress conditions (Niamh et al. , Biochem ., 1995, 34, 7430). To date, biochemical activity assays have been conducted for Apsin 1, Apsin 2, and Apsin 3 (Olsen et al., Biochem. J. , 1999, 339, 407), but so far biochemical activities for Apsin 6 and Apsin 7 There is no research report on this. However, based on the amino acid sequence, Apsin 6, like Apsin 1 and Apsin 2, is attached to cell membranes via GPI anchors, and Apsin 7 is expected to be inserted into the cell wall through additional processing (Graham et al., Mol. Microbiol., 2000, 38, 839).

To date, the identification of the physiological functions of these aptins remains an interesting basic task to be addressed, but for the purpose of production in Saccharomyces cerevisiae by the activity of these proteases in the case of Apsin 1 or Apsin 2 As reports of research reports that recombinant proteins are cleaved increase, apsin deficient yeast strains are attracting attention as industrial strains that are very useful for producing recombinant proteins, particularly foreign peptides with basic amino acids. Recombinant proteins reported to be cleaved by Apsin 1 include human serum albumin (Kerry-williams et al., Yeast, 1998, 14, 161), glucagon and glucagon like peptides (Egel-Mitani et al., Enzyme Microb. Technol. , 2000, 26, 671; US Pat. No. 6,110,703), human elapine precursors (Bourbonnais et al., Protein Exp. Purif. , 2000, 20, 485), and insect diuretic hormones have been reported to be involved in cleavage of absin 2 along with absin 1 (Copley et al., Biochem. J., 1998, 330, 1333).

Human parathyroid hormone (hereinafter referred to as 'hPTH') also uses yeast Saccharomyces cerevisiae as a host cell to secrete and produce proteins by the proteolytic enzymes of the yeast host cell itself. Most hPTH excretion cut off was a major obstacle to the industrial use of the yeast-based hPTH production system. In addition, the present inventors have YPS1 gene on the basis of prior findings that with a high concentration of L- seen when added to the culture medium inhibited significantly the cutting of hPTH (Chung et al., Biotechnol . Bioeng., 1998, 57, 245) Through the development of yeast strains that have been deficient, a yeast expression system was developed that was significantly prevented from degradation of hPTH (Korean Patent Registration No. 0024696; Kang et al., Appl.Microgiol. Biotechnol., 1998, 50, 187). Yeast strain ( YPS1 Δ YPS2 Δ YPS3 Δ) with simultaneous removal of YPS1, YPS2 and YPS3 to prevent degradation of hPTH (Chung et al., Process Biochem ., 2000, 35, 503) In addition, it has developed and patented a yeast host cell that prevented the degradation of hPTH by more than 90% at the end of the culture, which mimics the high concentration cell culture by galactose feeding (Korean Patent Publication No. 2002-17754). ). However, at the end of high cell culture using a fermentor, it was observed that a significant hPTH cleavage was still progressing in the YPS1 Δ YPS2 Δ YPS3 Δ strain. From this, it can be inferred that the cleavage of the recombinant protein proceeds due to the activity of the other auxin proteases other than Apsin 1, Apsin 2, and Apsin 3 in the late high cell culture conditions.

Accordingly, the present inventors prepare yeast variant strains lacking Apsin 6 and / or Apsin 7 and Apsin multiple deletion yeast variant strains in which Apsin 1, Apsin 2 and / or Apsin 3 are additionally deleted in addition to the gene, and the strain is The present invention was completed by confirming that the target protein was secreted in its complete form.

An object of the present invention is an absin-deficient yeast variant strain in which at least one gene selected from the group consisting of the Apsin 6 and Apsin 7 genes is deleted and at least one gene selected from the group consisting of Apsin 1, Apsin 2 and Apsin 3 is deleted. It is to provide a yeast mutant strain that has been made.

It is also an object of the present invention to provide a method for mass production of recombinant proteins using the auxin-deficient yeast variant strain.

In order to achieve the above object, the present invention is selected from the group consisting of Apsin-deficient yeast mutant strain lacking one or more genes selected from the group consisting of Apsin 6 and Apsin 7 gene and the above-mentioned Apsin 1, Apsin 2 and Apsin 3 Provided are Apsin deleted yeast variant strains in which one or more genes are deleted.

In addition, the present invention provides a method for mass production of recombinant protein using the aptin-deficient yeast variant strain.

Hereinafter, the present invention will be described in detail.

The present invention provides an Absin- deficient yeast variant strain in which at least one gene selected from the group consisting of Apsin 6 and Apsin 7 genes (hereinafter abbreviated as " YPS6 " and " YPS7 ", respectively) is deleted. It is further preferred that at least one gene selected from the group consisting of Apsin 1, Apsin 2 and Apsin 3 (hereinafter abbreviated as " YPS1 ", " YPS2 " and " YPS3 ", respectively) is deleted.

In the Apsin-deficient yeast variant strain of the present invention, the deleted gene is YPS1 / YPS6 , YPS2 / YPS6 , YPS3 / YPS6 , YPS1 / YPS2 / YPS6 , YPS1 / YPS3 / YPS6 , YPS2 / YPS3 / YPS6 , YPS1 / YPS2 / YPS3 / YPS6 , YPS1 / YPS7 , YPS2 / YPS7 , YPS3 / YPS7 , YPS1 / YPS2 / YPS7 , YPS1 / YPS3 / YPS7 , YPS2 / YPS3 / YPS7 , YPS1 / YPS2 / YPS3 / YPS7 and YPS1 / YPS2 / YPS3 / YPS6 / YPS6 It is preferably selected from the group consisting of, and more preferably, YPS1 / YPS2 / YPS3 / YPS6 or YPS1 / YPS2 / YPS3 / YPS6 / YPS7 is missing.

Yeast strains for the deletion of the Apsin gene include Saccharomyces cerevisiae, Hansenula polymorpha , Pichia pastoris , Yarrowia lipolytica , and Ski-irradiated caramyces It is preferred to be selected from the group consisting of Schizosaccharomyces pombe , more preferably to Saramyces cerevisiae.

When preparing the variant strain of the present invention, it is preferable to use a yeast selection label to delete the gene described above. Yeast screening labels are not particularly limited, but may be any one that can be popped out. In a preferred embodiment of the present invention, the URA3 selection label was used.

The present inventors have prepared an auxin quadruple-deleted yeast variant strain in which YPS1 , YPS2, YPS3 and YPS6 genes are simultaneously deleted, and an aptin- deficient yeast variant strain in which YPS1 , YPS2, YPS3 , YPS6 and YPS7 are simultaneously deleted. On 27, they were deposited with the Korea Institute of Biotechnology Gene Bank (Accession No .: KCTC 10384BP and KCTC 10385BP).

Yeast variant strain of the present invention

1) preparing a gene deletion expression vector comprising a gene segment encoding the N- and C-terminal portions of YPS1 , YPS2 , YPS3 , YPS6 or YPS7 and a cassette comprising a yeast selection marker gene;

2) removing the yeast selection gene by culturing the gene deletion expression vector prepared in step 1 in a pop-out capable medium;

3) separating the gene deletion cassette from the genomic DNA of the strain from which the yeast selection gene prepared in step 2 is removed;

4) inducing homologous recombination by transducing the gene deletion cassette isolated in step 3 into yeast; And

5) In step 4, homologous recombination is induced to prepare a variant strain in which the gene is deleted.

In a preferred embodiment of the present invention, a mutant strain is prepared by selecting one or more genes from the group consisting of the apsin genes YPS1 , YPS2 , YPS3, YPS6 and YPS7 of yeast Saccharomyces cerevisiae ( Fig. 1 , Fig. 2 and Table). 2 ), analysis of the degradation pattern of recombinant protein hPTH (human parathyroid hormone) and hLC I (human lipocotin I) secreted into the cell culture after introducing the recombinant protein gene into the single or multiple deletion mutant strains of the Apsin gene As a result, it was confirmed that degradation of the recombinant protein secreted by the mutant strain was significantly inhibited (see FIGS . 7 and 8 ).

The present invention also provides a method for mass production of a recombinant protein using the Apsin-deficient variant strain.

The recombinant protein mass production method of the present invention

1) introducing an expression vector comprising a recombinant protein gene using an auxin deletion variant strain as a host cell;

2) culturing the auxin deletion variant strain into which the recombinant protein gene prepared in step 1 is introduced; And

3) purifying the recombinant protein secreted after the culture of step 2.

In step 1, the apsin- deficient variant strain is preferably one or more genes selected from the group consisting of YPS6 and YPS7 genes, more preferably one or more genes selected from the group consisting of YPS1 , YPS2 and YPS3 . desirable.

In step 1, the recombinant protein gene is preferably a gene encoding a recombinant protein comprising a basic amino acid present in a single or pair. The recombinant protein is preferably selected from the group consisting of human serum albumin, glucagon, glucagon-like peptide, human elapine precursors, insect diuretic hormone, human parathyroid hormone (hPTH) and human lipocortin I (hLCI), and human parathyroid gland More preferably, it is a hormone or human lipocotin I gene.

The recombinant protein mass production method of the present invention uses a mutant strain lacking an apsin gene, in particular, a mutant strain lacking YPS1 , YPS2 and / or YPS3 genes in addition to the YPS6 and / or YPS7 genes as a host cell. Since the introduced mutant strain is used, it is possible to significantly inhibit the degradation of the recombinant protein by secretion of the protease of the auxin family produced by the yeast during high concentration culture, and thus the recombinant protein can be produced at high concentration and high yield.

Hereinafter, the present invention will be described in detail by way of examples.

However, the following examples are merely to illustrate the invention, but the content of the present invention is not limited to the following examples.

<Example 1> YPS6 Gene deletion of Saccharomyces cerevisiae mutant

<1-1> YPS6  Preparation of vector for gene deletion

In order to prepare the N-terminal and C-terminal fragments of the YPS6 gene required for homologous recombination to induce a YPS6 gene defect encoding apsin 6, primers were based on the nucleotide sequence of the YPS6 gene published in Genbank. PCR was performed after the preparation. Specifically, two pairs of oligonucleotides to be used as PCR primers were prepared based on the nucleotide sequence of the YPS6 gene (Acession # NP_012305) disclosed in Genbank. Primers for N-terminal fragments to facilitate subsequent genetic engineering processes include YPS6 N '-(F) primers as set forth in SEQ ID NO: 1 with an Eco Rl restriction enzyme recognition site at the 5'-end and 5'-end. A YPS6 N '-(R) primer set forth in SEQ ID NO: 2 containing a Bam Hl restriction enzyme recognition site was constructed. In addition, primers for C-terminal fragments include the YPS6 C '-(F) primer set forth in SEQ ID NO: 3 having the Bam Hl restriction enzyme recognition site at the 5'-end and the Xba l restriction enzyme recognition site at the 5'-end. A YPS6 C ′-(R) primer as set forth in SEQ ID NO: 4 was prepared . PCR (Perkin Elmer GeneAmp PCR) using chromosomal DNA of Saccharomyces cerevisiae as a transcript using a pair of primers of SEQ ID NO: 1 and SEQ ID NO: 2 or a pair of primers of SEQ ID NO: 3 and SEQ ID NO: 4 prepared above N-terminal (~ 700bp) and C-terminal fragment (~ 700bp) of the YPS6 gene were amplified by performing a 2400 thermal cycle. PCR reaction was performed 25 times for 30 seconds at 95 ℃, 30 seconds at 55 ℃, 60 seconds at 72 ℃. After the reaction, the prepared YPS6 N-terminal fragment was digested with Eco Rl / Bam Hl, and the C-terminal fragment was digested with Bam Hl / Xba l restriction enzyme and then digested with Eco Rl / Xbal pBluescript KS (+) vector ( Stratagene, La Jolla, Calif.) And connected, and named it 'pB- YPS6 NC'. URA3 pop-out selectable DNA (Kang et al ., Appl. Microbiol. Biotechnol., 2000, 53, 575-) as a Bam Hl restriction enzyme site between the YPS6 gene fragments of the pB- YPS6 NC vector prepared above. 582) was used to prepare a vector for the YPS6 gene deletion and named it 'pB- YPS6 :: URA3: tc5' ( FIG. 1A) .

<1-2> YPS6  Preparation of Deletion Mutant Strains

In order to prepare a YPS6 deletion strain, a homologous recombination was induced by introducing a YPS6 deletion DNA fragment into Saccharomyces cerevisiae strain. Specifically, the YPS6 deletion vector pB- YPS6 :: URA 3: tc5 prepared in Example <1-1> was digested with Eco Rl / Xba l, and then YPS6 deletion DNA fragments were prepared. Saccharomyces cerevisiae parent strain L3262 (Kang et al ., Appl. Microbiol. Biotechnol ., 2000, 53, 575-582) was transfected with the DNA fragment for YPS6 deletion prepared above. The transduced cells survived in the absence of uracil while incubating in uracil-deficient synthetic medium (SC-URA) (Laboratory course manual for methods in yeast genetics, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) Strains were selected. In order to remove the URA3 marker from the selected strain, the selected strain was plated and cultured on a plate containing 5'-FOA (5-fluoroorotate) medium (Adams et al ., Methods in yeast genetics, Cold Spring Harbor Laboratory Press, 1997). Cultivation of the URA3 gene pop-out through homologous recombination by culturing in the medium was selected ( YPS6 :: tc5 ' was named ( Fig. 1b ). In addition, by using the mutant strains (U.S. Patent Publication No. 2002-17754, Table 1 ) with the Ura- trait and deletion of the YPS1 , YPS2 and YPS3 genes, the mutant strains together with the YPS6 gene were prepared in the same manner as above ( Table 2 ).

 Strain  Characteristics of the strain (genotype) L3262 Saccharomyces cerevisiae parent strain ( MAT a ura3-52 leu2-3,112 his4-34 )  SLH11 YPS1 removed strain from L3262 ( MATa ura3-52 leu2-3,112 his4-34 YPS1 :: LEU2 )  SLH12 YPS2 removed strain from L3262 ( MATa ura3-52 leu2-3,112 his4-34 YPS2 :: HIS4 )  SLH14 YPS1 / YPS2 removed strains from L3262 ( MATa ura3-52 leu2-3,112 his4-34 YPS1 :: LEU2 YPS2 :: HIS4 )  SLH15 YPS3 removed strain from L3262 ( MATa ura3-52 leu2-3,112 his4-34 YPS3 :: tc5 )  SLH16 YPS1 / YPS3 removed strain from L3262 ( MATa ura3-52 leu2-3,112 his4-34 YPS1 :: LEU2 YPS3 :: tc5 )  SLH17 YPS2 / YPS3 Strains Removed from L3262 ( MATa ura3-52 leu2-3,112 his4-34 YPS2 :: HIS4 YPS3 :: tc5 )  SLH18 YPS1 / YPS2 / YPS3 removed strain from L3262 ( MATa ura3-52 leu2-3,112 his4-34 YPS1 :: LEU2 YPS2 :: HIS4 YPS3 :: tc5)

Strain Characteristics of the strain (genotype)   SLH19 YPS6 removed strain from L3262 ( MATa ura3-52 leu2-3,112 his4-34 YPS6 :: tc5 )   SLH20 YPS1 / YPS6 removed strain from L3262 ( MATa ura3-52 leu2-3,112 his4-34 YPS1 :: LEU2 YPS6 :: tc5 )   SLH21 Strains YPS1 / YPS3 / YPS6 removed from L3262 ( MATa ura3-52 leu2-3,112 his4-34 YPS1 :: LEU2 YPS3 :: tc5 YPS6 :: tc5 )   SLH22 YPS1 / YPS2 / YPS3 / YPS6 removed strain from L3262 ( MATa ura3-52 leu2-3,112 his4-34 YPS1 :: LEU2 YPS2 :: tc5 YPS3 :: tc5 YPS6 :: tc6 )   SLH23 Strains YPS1 / YPS2 / YPS3 / YPS6 removed from L3262 ( MATa ura3-52 leu2-3,112 his4-34 YPS1 :: LEU2 YPS2 :: HIS4 YPS3 :: tc5 YPS6 :: tc6 )   SLH24 YPS7 removed strain from L3262 ( MATa ura3-52 leu2-3,112 his4-34 YPS7 :: tc5 )   SLH25 YPS1 / YPS7 Strains Removed from L3262 ( MATa ura3-52 leu2-3,112 his4-34 YPS1 :: LEU2 YPS7 :: tc5 )   SLH26 YPS1 / YPS3 / YPS7 removed strain from L3262 ( MATa ura3-52 leu2-3,112 his4-34 YPS1 :: LEU2 YPS3 :: tc5 YPS7 :: tc5 )   SLH27 YPS1 / YPS2 / YPS3 / YPS7 removed strain from L3262 ( MATa ura3-52 leu2-3,112 his4-34 YPS1 :: LEU2 YPS2 :: HIS4 YPS3 :: tc5 YPS7 :: tc5 )   SLH28 YPS1 / YPS2 / YPS3 / YPS6 / YPS7 removed strain from L3262 ( MATa ura3-52 leu2-3,112 his4-34 YPS1 :: LEU2 YPS2 :: HIS4 YPS3 :: tc5 YPS6 :: tc6 YPS7 :: tc5 )   SLH29 YPS1 / YPS2 / YPS6 removed strains from L3262 ( MATa ura3-52 leu2-3,112 his4-34 YPS1 :: LEU2 YPS2 :: HIS4 YPS6 :: tc5 )   SLH30 YPS1 / YPS2 / YPS7 removed strain from L3262 ( MATa ura3-52 leu2-3,112 his4-34 YPS1 :: LEU2 YPS2 :: HIS4 YPS7 :: tc5 )

PCR was performed using the YPS6 F1 primers as set out in SEQ ID NO: 5 and the YPS6 R1 primers as set out in SEQ ID NO: 6 to confirm whether the YPS6 genes of the mutants were deleted on the chromosome. The PCR reaction results, is YPS6 gene whereas the wild type strain a DNA fragment of 2.7 kb size of the amplified mutant deficient in the amplified DNA fragment of 1.7 kb in size was confirmed that the gene defect YPS6 (A in Fig. 3).

<Example 2> YPS7 Gene deletion of Saccharomyces cerevisiae mutant

<2-1> YPS7  Preparation of vector for gene deletion

The YPS7 gene deletion vector encoding Apsin 7 was prepared in the same manner as in the production method of the YPS6 deletion vector described in Example 1 above. Specifically, two pairs of oligonucleotides to be used as PCR primers were prepared based on the nucleotide sequence of the YPS7 gene (Acession # NP_010636) disclosed in Genbank. Primers for N-terminal fragments to facilitate subsequent genetic engineering processes include YPS7 N '-(F) primers as set forth in SEQ ID NO: 7 having an Eco Rl restriction enzyme recognition site at the 5'-end and 5'-end. A YPS7 N '-(R) primer set forth in SEQ ID NO: 8 containing a Bam Hl restriction enzyme recognition site was constructed. In addition, primers for C-terminal fragments include YPS7 C '-(F) primer as set forth in SEQ ID NO: 9 having a Bam Hl restriction enzyme recognition site at the 5'-end and Xba l restriction enzyme recognition at the 5'-end. A YPS7 C '-(R) primer as set forth in SEQ ID NO: 10 containing the site was prepared . PCR (Perkin Elmer GeneAmp PCR) using chromosomal DNA of Saccharomyces cerevisiae as a transcript using a pair of primers of SEQ ID NO: 7 and SEQ ID NO: 8 or a pair of primers of SEQ ID NO: 9 and SEQ ID NO: 10 prepared above 2400 thermal cycle reactions were used to amplify the N-terminal (~ 700bp) and C-terminal fragments (~ 700bp) of the YPS7 gene. PCR reaction was performed 25 times for 30 seconds at 95 ℃, 30 seconds at 55 ℃, 60 seconds at 72 ℃. The YPS7 N-terminal fragments prepared after the reaction were digested with Eco Rl / Bam Hl, and the C-terminal fragments were digested with Bam Hl / Xba l restriction enzymes, followed by pBluescript KS (+) vector digested with Eco Rl / Xbal. The inserted vector was prepared and named 'pB- YPS7 NC'. A Bam Hl restriction enzymes place that exists between the end piece of a gene YPS7 pB- YPS7 NC vector prepared above by introducing a URA3 pop-out selection marker DNA prepared vector for YPS7 gene defect and it 'pB- YPS7 :: URA3: tc5 '( FIG. 2A ).

<2-2> YPS7  Preparation of Deletion Mutant Strains

In the preparation of the YPS7 deletion mutant strain, the homologous recombination was induced by introducing the YPS7 deletion DNA fragment into Saccharomyces cerevisiae strain as in Example 1. Specifically, the YPS7 deletion vector pB- YPS7 :: URA 3: tc5 prepared in Example <2-1> was digested with Eco Rl / Xba l, and then a YPS7 deletion DNA fragment was prepared. Saccharomyces cerevisiae parent strain L3262 was transfected with the DNA fragment for YPS7 deletion prepared above. The transfected cells were cultured in synthetic medium (SC-URA) lacking only uracil, and the strains that survived uracil deficiency were selected. In order to remove the URA3 marker from the selected strain, the selected strain was plated and cultured on a plate containing 5'-FOA (5-fluoroorotate) medium (Adams et al ., Methods in yeast genetics, Cold Spring Harbor Laboratory Press, 1997). Cultivation of the URA3 gene pop-out through homologous recombination by culturing in the medium was named ' YPS6 :: tc5' ( Fig. 2b ). Further, while the Gini Ura- transformants YPS1, YPS2 and YPS3 genes are then produced in which a mutant strain with a defect YPS7 gene using a mutant deficient (Republic of Korea Patent Publication No. 2002-17754 call, Table 1) in the same manner as The strains were named as described in Table 2 ( Table 2 ). PCR was performed using the YPS7 F1 primers as set out in SEQ ID NO: 11 and the YPS7 R1 primers as set out in SEQ ID NO: 12 to determine if the YPS7 gene on these mutant chromosomes was deleted. As a result of the PCR reaction, the 2.5 kb DNA fragment was amplified in the wild-type strain, while the YPS7 gene was deficient in a 1.5 kb DNA fragment amplified and confirmed that the YPS7 gene was deleted ( FIG. 2B ).

That the inventors have added YPS6 gene at the same time, defects that check aepsin quadruple mutant of 'SLH23 (YPS1ΔYPS2ΔYPS3ΔYPS6Δ)' termed, add the YPS6 and YPS7 gene defect at the same time as the YPS1, YPS2 and YPS3 gene in the YPS1, YPS2 and YPS3 genes The identified Absin quinine mutant strain was named 'SLH28 ( YPS1ΔYPS2ΔYPS3ΔYPS6ΔYPS7Δ )' and was deposited on November 27, 2002 to the Korea Biotechnology Research Institute Gene Bank (Accession Number; KCTC 10384BP, KCTC 10385BP).

Example 3 Growth Characteristics of Apsin Multiple Deletion Mutant

<3-1> Growth rate measurement

Physiological characteristics of the Apsin protease deletion mutants ( Table 2 ) prepared in Example 1 and Example 2 were analyzed. First, aepsin gene defect but a variant of the YPS1 SLH11 (YPS1 Δ), the deficit double mutants defective gene YPS1 and YPS2 SLH14 (YPS1 Δ YPS2Δ), YPS1 , YPS2, triple deletion mutant of YPS3 gene defect SLH18 (YPS1 Δ YPS2ΔYPS3Δ), YPS1 , YPS2, YPS3, the YPS6 gene defect quadruple deletion mutant SLH23 (YPS1 Δ YPS2ΔYPS3ΔYPS6Δ), YPS1 , YPS2 Growth patterns were compared and analyzed under various culture conditions to analyze the physiological characteristics of the quinine mutant strain SLH28 ( YPS1 Δ YPS2ΔYPS3ΔYPS6ΔYPS7Δ ), in which all of the genes YPS3, YPS6, and YPS7 were deleted. First, in order to analyze the growth rate of the mutant strain, the strains prepared above were inoculated in 3 ml of liquid YPD medium (1% of yeast extract, 2% of Bakto peptone, and 1% of glucose), respectively, for 16 hours at 30 rpm and 190 rpm. Incubated. After the culture, the culture medium was taken when OD ₆₀₀ became 1 (when the OD was 1, the number of cells was 3 × 10 ⁷ cells / ml), and the culture medium was 3 × 10 ⁶ cells / ml, 3 × 10 ⁵ Cell growth rate was analyzed by dividing the cells to a number of cells / ml, 3 × 10 ⁴ cells / ml, and 3 × 10 ³ cells / ml and spotting the plate medium.

As a result, the Apsin mutants showed almost the same growth rate as the wild type, but the growth rate of SLH28, a quintet of the Absin mutant strains, in which five absin genes were simultaneously deleted, was slightly reduced compared to the wild type ( FIG. 4A ).

<3-2> Sensitivity investigation to temperature

In order to analyze the temperature sensitivity of the mutant strains, the mutant strains were spotted on YPD medium under the same conditions as in Example <3-1>, and then 48 hours at 37 ° C and 30 ° C, 72 hours at 20 ° C, and 120 at 16 ° C. Incubated under the conditions of time. After the incubation, the degree of growth of the cells in each culture condition was measured to analyze the temperature sensitivity.

As a result, SLH14, an apson double-defective mutant, did not grow at high temperatures at 37 ° C, compared to wild-type strains, and SLH18, SLH23, and SLH28, triple, quadruple-defective and mutant strains, did not grow much more clearly than the Epson double-defective mutants. Apsin multiple mutants were not sensitive to high temperature, unlike wild type. However, the Apsin mutants were grown to the same level as the wild type without any decrease in growth at normal temperature 30 ℃ and low temperature 20 ℃ and 16 ℃ ( Fig. 4b ).

<3-3> Investigation of sensitivity to antibiotics and osmotic pressure

To analyze the effect of antibiotics on the growth of apsin-deficient mutants, 50 μg / ml of hygromycin B (Sigma, St. Louis, Mo.) was added to YPD medium to determine the auxin multiple-defective strains. Incubation at ° C. resulted in that all the Absin multiple deletion mutants did not grow.

In addition, 1M sorbitol, an osmotic stabilizer, was added to YPD medium to analyze the effect of the osmotic pressure on the growth of auxin-deficient mutant strains. Cell growth was restored to the level of wild type strains compared to culture without the addition of sorbitol. Through the above results, it can be seen that the cell wall of the Apsin multiple deletion mutants are weaker than the wild type.

<3-4> Sensitivity investigation to pH

In order to analyze the pH sensitivity of apsin-deficient mutant strains, wild type strains and apsin-deficient mutants were cultured under acidic conditions of pH 3.5 and alkaline conditions of pH 8.0 to analyze their growth. Specifically, the pH was adjusted to pH 3.5 by adding 0.05 M succinic acid buffer (pH 3.0) to YPD medium or pH 8.0 by adding p.1 M Tris buffer (Tris-Cl, pH 8.25) to YPD medium. After preparing the adjusted medium was cultured by spattering the Apsin multiple deletion mutants prepared above. As a result, in the acidic and alkaline conditions, YPS1- only mutant SLH11 was grown, while Apsin multiple-defective mutants SLH14 , SLH18 , SLH23 , and SLH28 did not grow, and were cultured with 1M sorbitol as an osmotic stabilizer. As a result, growth was not recovered under acidic conditions, but growth was slightly recovered under pH 8.0 alkaline conditions ( FIG. 5A ).

<3-5> Sensitivity investigation to salt

In order to analyze the sensitivity of the salts of the auxin multiple-defective mutants, the growth rate of the auxin multiple-defective mutants was incubated in YPD medium to which 0.4M NaCl or 0.8M NaCl was added. As a result, the growth of Apsin multiple deletion strains grew well as wild type in the medium containing 0.4M NaCl, while the strains of SLH18 , SLH23 and Growth of SLH28 was somewhat reduced ( FIG. 5B ).

As described above, the apsin-deficient mutants showed a physiological characteristic that the growth is rapidly decreased or does not survive under stress conditions such as high temperature, high salinity, and extreme pH compared to wild-type strains. Thus, it can be seen that auxin proteases are not necessary for cell survival under normal culture conditions, but are involved in the processing of proteins that perform the functions necessary for cells to live in resistance under various stress conditions.

Example 4 Analysis of the Effect of Apsin Deficient Mutants on the Degradation of Recombinant hPTH

<4-1> Growth Analysis of Apsin Deficient Mutant with Recombinant hPTH

Of the Apsin mutant strains produced in Examples 1 and 2, SLH23 ( YPS1ΔYPS2ΔYPS3ΔYPS6Δ ), which is a quadrupled Apsin deletion mutant, and the quinacrine Apsin- deficient strain SLH28 ( YPS1ΔYPS2ΔYPS3ΔYPS6Δ ), which were simultaneously deleted with five Apsin genes, were host cells. By expressing recombinant human parathyroid hormone ( HPTH ) and culturing a high concentration of cells, the strain together with the case of using the Apsin triple defect strain SLH18 ( YPS1ΔYPS2ΔYPS3Δ ) developed in the preceding invention (Korean Patent Publication No. 2002-17754) as a host cell Of growth was analyzed. Specifically, pG10-hPTH (Chung et al.) , A saccharomyces cerevisiae plasmid having an hTPH expression cassette consisting of the GAL10 promoter :: ppL :: hPTH gene :: GAL7 terminator gene, is a vector for expressing hPTH. , Biotechnol. Bioeng ., 1998, 57, 245). The pG10-hPTH expression vector was transfected into SLH18, SLH23 and SLH28 mutant strains, and the selected mutant strains were cultured by fed-batch culture using galactose and ethanol as feeding media (Songet et al ., Process Biochemistry , 2000, 35, 503). First, the selected mutant strains were cultured in 10 ml of YNBCAD (yield nitrogen base without 0.67% amino acid, 2% glucose and 0.5% casamino acid) medium, and the seed of the culture was flask cultured in 100 ml YNBCAD medium. It was then inoculated in 2.5 L of the main culture (glucose 20 g / L, yeast extract 40 g / L, casamino acid 5 g / L and KH ₂ PO ₄ 10 g / L). 800 g / l of ethanol and 400 g / l of galactose were prepared as a feeding medium, and the concentrations of ethanol and galactose were adjusted to 20 g / l and 10 g / l, respectively. The feeding method is to induce the expression of foreign protein and sustain cell growth by adding ethanol and galactose after the initial carbon source of glucose is depleted. After 12 hours of incubation, the glucose was consumed and ethanol and galactose were added. Thereafter, the feeding medium was intermittently supplied so that the concentration in the culture medium was 20 g / l for ethanol and 10 g / l for galactose, respectively, as the pH and cell concentration increased. Incubation temperature and pH were kept constant at 30 ° C. and 5.5, respectively.

As a result, in the SLH18 mutant strains, the growth rate of the cells increased steadily after 30 hours, but the SLH23 and SLH28 mutants entered the stationary phase after 30 hours, but continued to consume galactose and ethanol. The concentration no longer increased ( FIG. 6 ).

<4-2> Expression of hPTH Secretion in Recombinant hPTH-Induced Apsin Deficient Mutant

The effect of the absin deficiency on the secretion of hPTH produced by recombinant hPTH introduced strains was analyzed. Specifically, after culturing the Apsin-deficient mutant strain prepared in Example <4-1>, the cell culture medium was obtained, precipitated with TCA (trichloroacetic acid), electrophoresed and separated by SDS-PAGE, and then subjected to Coomassie staining. Stained.

As a result, the degradation tendency of hPTH secreted and accumulated in the culture medium tended to decrease the amount of hPTH in the relatively full size as SLH18 increased the fragments located at 6 kDa and 4 kDa as the fermentation time passed ( Fig. 7 A ). However, in the case of SLH23 and SLH28, although the amount of hPTH of a full size tends to remain constant to some extent, the tendency of hPTH degradation is suppressed compared to SLH18 ( FIG . 7B , C of FIG. 7 ). Thus, the high density cell culture experiments to aepsin genes YPS1, the aepsin the triple deletion mutant SLH18 defect to YPS2 and YPS3 (YPS1ΔYPS2ΔYPS3Δ) than YPS6 and / or YPS7 SLH23 gene is an additional strain deficient in (YPS1ΔYPS2ΔYPS3ΔYPS6Δ) through and SLH28 ( By confirming that the degradation of hPTH secreted into the culture medium in YPS1ΔYPS2ΔYPS3ΔYPS6ΔYPS7Δ ) was significantly inhibited, the Apsin multiple-defective mutants with additional deletion of the YPS6 and / or YPS7 genes were suitable as host cells producing full-form hPTH with high yield. Could know.

Example 5 Analysis of Human Lipocortin Secretion Expression in Apsin Deficient Mutants

Human lipocortin-I (hLC I) is a representative protein that increases intracellular and intracellular concentrations when glucocorticoids are administered as steroid hormones and inhibits phospholipase A ₂ (PLA ₂ ) activity in vitro. It also has the function of binding to phospholipids in the presence of calcium. Since lipocortin is involved in anti-inflammatory activity that inhibits the activity of PLA ₂ involved in the inflammatory response in vivo, it has been interested in developing it as a recombinant medicinal protein, and expression has been attempted in various host cell systems so far (Wallner). et al ., Nature , 1990, 320, 77; Huh et al ., Kor. Biochem. J. , 1990, 23, 459; Giga-Hama et al ., Bio / Technol, 1994, 12, 400). HLC I with a molecular weight of 37 kDa consists of 346 amino acids (Wong et al. , Biochem. J , 1991, 15 , 313) In particular, the single or pair of basic amino acid contents are very high, so that the expression of secretion in yeast is very likely to be attacked by aptin proteases. Indeed, when the inventors attempted to express hLC I in Saccharomyces cerevisiae, it was pointed out that the expression efficiency of hLC I was secreted into hLC I in a highly degraded form (Chung et al . , Biotechnol. Bioeng ., 1996, 49, 473).

In order to investigate whether aptin proteases are involved in the degradation of recombinant hLCI secreted and expressed in Saccharomyces cerevisiae, Several auxin deficiency strains were used as host cells to express recombinant hLC I and then compared with wild type. Specifically, a vector for expressing human lipocortin is pYGLP10 (Chung et al.) , A saccharomyces cerevisiae plasmid having an expression cassette consisting of GAL10 promoter :: ppL :: lipotin gene :: GAL7 terminator gene. al ., J. Ferment. Bioeng ., 1997, 84, 446). In the same manner as in Example 4, the pYGLP10 expression vector was transfected into the Apsin-deficient strain of the present invention and cultured in high concentration cells through galactose and ethanol feeding. The cell culture medium obtained after 24 hours of culture was obtained, precipitated with TCA, separated by electrophoresis using SDS-PAGE, and stained by Coomassie staining. In addition, the gel electrophoresed by SDS-PAGE was transferred to a nitrocellulose filter for 30 minutes at 100V using a transfer buffer (10 mM CAPS), followed by TBST buffer (TBS (0.15 M NaCl, 0.05 M Tris). Monoclonal antibody (BD bioscience) that specifically recognizes hLCI after treatment with -Cl (pH 7.4), 0.005% Tween20), 0.05% Tween20) and BSA (Bovine serum albumin) for 30 minutes at room temperature 1: After adding to 5000, the mixture was reacted for 1 hour 30 minutes, and washed three times with TBST. This was treated with alkaline phosphatase fusion secondary antibody (Biorad, Hercules, CA) for 1 hour 30 minutes, washed with TBST and developed using NBT and BCIP.

As a result, in the wild type strains, almost all recombinant hLCIs were degraded, so that the intact size of 37 kDa hLC I was hardly observed, and only 31 kDa degradation product d2 was observed as the main protein accumulated in the culture medium. In addition, the strain SLH11 ( YPS1Δ ) lacking the YPS1 gene had a slightly reduced d2 degradation product and a proportionately increased size of 34 kDa lipocotin degradation product, but still intact. hLC I was not observed. In contrast, in the case of a multi-apsin-deficient strain in which two or more aptin genes were deleted, it was confirmed that intact hLCI accumulated in the culture medium ( FIG. 8A ).

In addition, as a result of analyzing the culture medium secured after incubating the strain for 48 hours, in the SLH14 ( YPS1ΔYPS2Δ ), which is an apsin double-defective strain , another form of 32 kDa-sized hLCI degradation product d3 was observed. In the mutant strain SLH18 ( YPS1ΔYPS2ΔYPS3Δ) , a part of d3 degraded hLCI was observed ( FIG. 8B ). In addition, as a result of analyzing the culture medium obtained after 72 hours of incubation of the strain, in the case of the SLH18 strain is decomposed d3 form hLC I is a more large amount of accumulation, but, in SLH23 (YPS1ΔYPS2ΔYPS3ΔYPS6Δ) aepsin quadruple mutant, mutant Five Fold In SLH28 ( YPS1ΔYPS2ΔYPS3ΔYPS6ΔYPS7Δ ), almost no d3 degraded hLCI could be observed ( FIG. 8C ).

Thus, YPS1, YPS2, YPS3 addition YPS6 and YPS7 This is involved in cutting the recombinant Lipo kotin, lipoic kotin order to increase the high density cell culture when fully formatted reports kotin expression efficiency for mass production that contains the YPS6 or YPS7 gene defect aepsin multiple Defective mutants were found to be suitable host cells.

From the above results, the Apsin multiple-defective yeast strain of the present invention can be usefully used industrially by reducing the protease activity of cleaving the extracellular secreted recombinant protein, allowing the desired protein to be isolated and purified in its intact form.

Is a schematic diagram showing an out (pop-out) capable of URA3 selection cassette production process for YPS6 gene-deficient using the cover, - Figure 1a My process celebrity bicyclic trying to pop from the yeast Saccharomyces

Figure 1b is a schematic diagram showing a process of recovering the URA3 selection marker after inducing homologous recombination with the YPS6 gene of the yeast Saccharomyces cerevisiae strain using the YPS6 gene deletion cassette,

It is a schematic diagram showing a possible out of the URA3 selection gene cassette production process for YPS7 deficit with a cover-2a is my Seth Serenity Vichy trying to pop from the yeast Saccharomyces

Figure 2b is a schematic diagram showing a process of recovering the URA3 selection marker after inducing homologous recombination with the YPS7 gene of the yeast Saccharomyces cerevisiae strain using the YPS7 gene deletion cassette,

Figure 3 is a PCR electrophoresis picture confirming whether YPS6 gene deletion (A) and YPS7 gene deletion (B) in Saccharomyces cerevisiae Apsin multiple deletion mutant strain ,

4A is A graph showing the growth curve of cells after flask culture of Saccharomyces cerevisiae Apsin multiple deletion mutant strain,

4b is Saccharomyces cerevisiae Absin multi-defective mutant plate culture after the photo showing the growth pattern at various culture temperatures,

Lane 1: L3262 (WT), lane 2: SLH11 ( YPS1 Δ),

Lane 3: SLH14 ( YPS1 Δ YPS2 Δ), lane 4: SLH18 ( YPS1 Δ YPS2 Δ YPS3 Δ),

Lane 5: SLH23 ( YPS1 Δ YPS2 Δ YPS3 Δ YPS6 Δ),

Lane 6: SLH28 ( YPS1 Δ YPS2 Δ YPS3 Δ YPS6 Δ YPS7 Δ)

Figure 5a is a photograph showing the pH sensitivity of Saccharomyces cerevisiae Apsin multiple deletion variant strain,

Lane 1: L3262 (WT), lane 2: SLH11 ( YPS1 Δ),

Lane 3: SLH14 ( YPS1 Δ YPS2 Δ), lane 4: SLH18 ( YPS1 Δ YPS2 Δ YPS3 Δ),

Lane 5: SLH23 ( YPS1 Δ YPS2 Δ YPS3 Δ YPS6 Δ),

Lane 6: SLH28 ( YPS1 Δ YPS2 Δ YPS3 Δ YPS6 Δ YPS7 Δ)

5B is a photograph showing the salt susceptibility of Saccharomyces cerevisiae Apsin multiple deletion variant strain,

Lane 1: L3262 (WT), lane 2: YSH444 (MATa hog1 :: TRP1),

Lane 3: SLH11 ( YPS1 Δ), lane 4: SLH14 ( YPS1 Δ YPS2 Δ),

Lane 5: SLH18 ( YPS1 Δ YPS2 Δ YPS3 Δ),

Lane 6: SLH23 ( YPS1 Δ YPS2 Δ YPS3 Δ YPS6 Δ),

Lane 7: SLH28 ( YPS1 Δ YPS2 Δ YPS3 Δ YPS6 Δ YPS7 Δ)

Figure 6a is a graph showing the cell growth curve after the fed-batch culture using galactose and ethanol as a feed medium after introducing a recombinant human parathyroid hormone expression vector using SLH18 ( YPS1ΔYPS2ΔYPS3Δ ) as an auxin triple deletion strain as a host cell. ego,

FIG. 6B is a graph showing cell growth curve after fed-batch culture using galactose and ethanol as feeding medium after introducing recombinant hPTH expression vector using SLH23 ( YPS1ΔYPS2ΔYPS3ΔYPS6Δ ), which is an aptsin quadruple deletion strain , as a host cell, and FIG.

6C is a graph showing cell growth curve after fed-batch culture using galactose and ethanol as a feeding medium after introducing hPTH recombinant expression vector using SLH28 ( YPS1ΔYPS2ΔYPS3ΔYPS6ΔYPS7Δ ) as a host cell,

Figure 7 shows the Apsin triple deletion strain SLH18 ( YPS1ΔYPS2ΔYPS3Δ ) ( A ) with the hPTH expression vector, Apsin quadruple deletion strain SLH23 ( YPS1ΔYPS2ΔYPS3ΔYPS6Δ ) ( B ), Apsin quinine defect variant SLH28 ( YPS1Δ / ΔΔ / YΔ2 / YPS2 C ) is a photograph comparing and analyzing the degradation pattern of hPTH secreted by the high concentration of cell culture by SDS-PAGE,

FIG. 8A shows Coomassie staining or western blot after performing SDS-PAGE using a culture obtained 24 hours after induction of high concentration of several auxin-defective mutants expressing recombinant human lipocotin secretion by intermittent galactose feeding. Electrophoresis picture showing the results of analyzing the expression and degradation of lipocotin,

FIG. 8B shows the electrophoresis of Coomassie stained after SDS-PAGE using a culture medium obtained after 48 hours of induction of high concentration of various auxin-deficient mutants expressing recombinant human lipocotin secretion by intermittent galactose supply. It is a photograph,

FIG. 8c shows electrophoresis stained with Coomassie after performing SDS-PAGE using a culture medium obtained after 72 hours of induction of high concentration of various auxin-deficient mutants expressing recombinant human lipocotin secretion by intermittent galactose supply. It is a photograph.

<110> Korea Research Institute of Bioscience and Biotechnology <120> Yeast mutant strains deficient in the multiple yapsin genes and method for the production of recombinant proteins using the same <130> 2p-12-23 <160> 12 <170> KopatentIn 1.71 <210> 1 <211> 28 <212> DNA <213> Artificial Sequence <220> <223> YPS6N '-(F) <400> 1 ttaagaattc atacgagcgt catatgtc 28 <210> 2 <211> 29 <212> DNA <213> Artificial Sequence <220> <223> YPSN '-(R) <400> 2 cggaggatcc taaaacggtc aatgaacac 29 <210> 3 <211> 31 <212> DNA <213> Artificial Sequence <220> <223> YPS6C '-(F) <400> 3 tcccggatcc tttagtacat gggtatataa g 31 <210> 4 <211> 28 <212> DNA <213> Artificial Sequence <220> <223> YPS6C '-(R) <400> 4 actttctaga acaatacctc aagctacc 28 <210> 5 <211> 28 <212> DNA <213> Artificial Sequence <220> <223> YPS6 F1 <400> 5 ttaagaattc atacgagcgt catatgtc 28 <210> 6 <211> 28 <212> DNA <213> Artificial Sequence <220> <223> YPS6 R1 <400> 6 actttctaga acaatacctc aagctacc 28 <210> 7 <211> 30 <212> DNA <213> Artificial Sequence <220> <223> YPS7N '-(F) <400> 7 ctatgaattc cagtgctttg tatcataccg 30 <210> 8 <211> 30 <212> DNA <213> Artificial Sequence <220> <223> YPS7N '-(R) <400> 8 gataggatcc actagcaaac gttggcgttg 30 <210> 9 <211> 29 <212> DNA <213> Artificial Sequence <220> <223> YPS7C '-(F) <400> 9 gtcaggatcc atgttcactg tcccaggtc 29 <210> 10 <211> 29 <212> DNA <213> Artificial Sequence <220> <223> YPS7C '-(R) <400> 10 gtgttctaga ggataggtct gcaaaacac 29 <210> 11 <211> 30 <212> DNA <213> Artificial Sequence <220> <223> YPS7 F1 <400> 11 ctatgaattc cagtgctttg tatcataccg 30 <210> 12 <211> 29 <212> DNA <213> Artificial Sequence <220> <223> YPS7 R1 <400> 12 gtgttctaga ggataggtct gcaaaacac 29

Claims (9)

YPS (aepsin, yapsin (yeast aspartic protease, yeast aspartic protease); hereinafter 'YPS' La abbreviated as) 6 and one or more genes selected from the group are missing and Saccharomyces My process celebrity bicyclic Ke (Saccharomyces cerevisiae) as consisting of YPS7 Apsin missing yeast variant strain selected from the group consisting of, Hansenula polymorpha , Pichia pastoris , Yarrowia lipolytica , Schizosaccharomyces pombe . 2. The yeast variant strain according to claim 1, wherein at least one gene selected from the group consisting of YPS1 , YPS2 and YPS3 is further deleted. The strain according to claim 1, wherein the yeast is Saccharomyces cerevisiae. 3. The SLH23 ( YPS1 Δ YPS2 Δ YPS3 Δ YPS6 Δ) strain according to claim 2, wherein the YPS1 , YPS2 , YPS3 and YPS6 genes are deleted; (Accession Number: KCTC 10384BP). The strain SLH28 ( YPS1 Δ YPS2 Δ YPS3 Δ YPS6 Δ YPS7 Δ) strain according to claim 2, wherein the YPS1 , YPS2 , YPS3 , YPS6 and YPS7 genes are deleted; (Accession No .: KCTC 10385BP). 1) introducing an expression vector comprising a recombinant protein gene using the apsin-deficient variant strain of any one of claims 1 to 5 as a host cell; 2) culturing the auxin deletion variant strain into which the recombinant protein gene prepared in step 1 is introduced; And 3) A method for mass production of recombinant protein comprising the step of purifying the recombinant protein secreted after the culture of step 2. 7. The method of claim 6, wherein the recombinant protein gene is a gene encoding a recombinant protein comprising basic amino acid residues present in single or pair. 8. The method of claim 7, wherein the recombinant protein is selected from the group consisting of human serum albumin, glucagon, glucagon-like peptide, human elapine precursors, insect diuretic hormone, human parathyroid hormone, and human lipocotin I. The method of claim 8, wherein the recombinant protein is human parathyroid hormone or human lipocotin I. 10.